Advised on Purchase of Company

Materials, Chemicals & Mining

ABE Capital Partners

Private Equity Fund Spain

Acquired Investment Interest in Seller's Business

Oleofat

Advanced treatment of biofuels for reutilization in specialty chemicals Spain

ABE Capital Partners Acquired Investment Interest in Seller's Business Oleofat

Private Equity firm ABE CAPITAL PARTNERS – specializing in investment in small and medium-sized enterprises with high growth potential – has taken a significant stake in Oleofat, a leading business group in the processing of oily residues. The investment made by ABE in Oleofat’s corporate capital will support the company’s consolidation in the advanced biofuels sector and the group’s expansion into markets with a higher added value, such as cosmetics or nutraceuticals.

 

Oleofat, which began operations in 2015 under the leadership of Rafael Lavín, current CEO of the group, has its head office in Vitoria-Gasteiz (Alava), and it has production facilities in Tudela and Caparroso (Navarre). The business group has seen strong growth in recent years, with turnover in excess of 40 million euros. Part of the group’s success lies in its investment in assets, which has allowed the company to make a qualitative leap in how it extracts value from its by-products in order to generate products with a high added value, such as active ingredients used in the cosmetics and nutraceuticals industries.

 

Constant investment in top-level technology and infrastructure, together with the support of the committed dedication of its R&D department, has allowed it to expand its product range and transition towards products with higher complexity.

 

ABE Capital Partners is a private equity firm established in late 2019. It focusses on long-term investment in Small & Medium Enterprises (SMEs) with high growth potential, and its main geographical area of interest is the Basque Country. The ABE value proposal is characterized by maintaining a long-term vision throughout the whole of the investment cycle, with a flexible investment time horizon and a strategy of organic and inorganic growth in all companies in which it invests.

Experts who worked on the transaction